168 related articles for article (PubMed ID: 36494261)
1. Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy - The randomized NORDIC9-study.
Liposits G; Ryg J; Skuladottir H; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Glimelius B; Sorbye H; Pfeiffer P
J Geriatr Oncol; 2023 Jan; 14(1):101408. PubMed ID: 36494261
[TBL] [Abstract][Full Text] [Related]
2. External validation and diagnostic value of the Elderly Functional Index version 2.0 for assessing functional status and frailty in older Danish patients with gastrointestinal cancer receiving chemotherapy: A prospective, clinical study.
Jespersen E; Soo WK; Minet LR; Eshoj HR; King MT; Pfeiffer P; Möller S
J Geriatr Oncol; 2024 Jan; 15(1):101675. PubMed ID: 38070322
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study.
Liposits G; Skuladottir H; Ryg J; Winther SB; Möller S; Hofsli E; Shah CH; Poulsen LØ; Berglund Å; Qvortrup C; Osterlund P; Johansen JS; Glimelius B; Sorbye H; Pfeiffer P
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233472
[TBL] [Abstract][Full Text] [Related]
4. G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.
Shah M; Noronha V; Ramaswamy A; Gattani S; Mokal S; Joshi A; Patil V; Menon N; Banavali S; Badwe R; Prabhash K
J Geriatr Oncol; 2022 Jun; 13(5):720-730. PubMed ID: 35283049
[TBL] [Abstract][Full Text] [Related]
5. Frailty screening for predicting rapid functional decline, rapid progressive disease, and shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy - a prospective, clinical study.
Jespersen E; Winther SB; Minet LR; Möller S; Pfeiffer P
J Geriatr Oncol; 2021 May; 12(4):578-584. PubMed ID: 33830020
[TBL] [Abstract][Full Text] [Related]
6. Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial.
Winther SB; Liposits G; Skuladottir H; Hofsli E; Shah CH; Poulsen LØ; Ryg J; Osterlund P; Berglund Å; Qvortrup C; Glimelius B; Sorbye H; Pfeiffer P
Lancet Gastroenterol Hepatol; 2019 May; 4(5):376-388. PubMed ID: 30852136
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.
Cavdar E; Iriagac Y; Karaboyun K; Avci O; Seber ES
J Geriatr Oncol; 2022 Jul; 13(6):821-827. PubMed ID: 35361561
[TBL] [Abstract][Full Text] [Related]
8. Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS).
Decoster L; Kenis C; Naessens B; Houbier G; De Man M; Lambrecht G; Monsaert E; Moons V; Vergauwe P; Prenen H; Van Cutsem E; Wildiers H
J Geriatr Oncol; 2018 Mar; 9(2):93-101. PubMed ID: 29133190
[TBL] [Abstract][Full Text] [Related]
9. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
[TBL] [Abstract][Full Text] [Related]
10. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.
Soubeyran P; Bellera C; Goyard J; Heitz D; Curé H; Rousselot H; Albrand G; Servent V; Jean OS; van Praagh I; Kurtz JE; Périn S; Verhaeghe JL; Terret C; Desauw C; Girre V; Mertens C; Mathoulin-Pélissier S; Rainfray M
PLoS One; 2014; 9(12):e115060. PubMed ID: 25503576
[TBL] [Abstract][Full Text] [Related]
11. Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9.
Winther SB; Österlund P; Berglund Å; Glimelius B; Qvortrup C; Sorbye H; Pfeiffer P;
BMC Cancer; 2017 Aug; 17(1):548. PubMed ID: 28814275
[TBL] [Abstract][Full Text] [Related]
12. Measures of functional status in older patients treated with palbociclib for advanced breast cancer.
Karuturi MS; Cappelleri JC; Blum JL; Patel K; Telivala B; McCune S; Cuevas JD; Lakhanpal S; Montelongo MZ; Wang Y; Tripathy D; Rocque GB
J Geriatr Oncol; 2024 Jan; 15(1):101670. PubMed ID: 38061288
[TBL] [Abstract][Full Text] [Related]
13. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
[TBL] [Abstract][Full Text] [Related]
14. The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.
Kim VS; Yang H; Timilshina N; Breunis H; Emmenegger U; Gregg R; Hansen AR; Tomlinson G; Alibhai SMH
J Geriatr Oncol; 2023 Mar; 14(2):101417. PubMed ID: 36682218
[TBL] [Abstract][Full Text] [Related]
15. Frailty and treatment outcome in advanced gastro-oesophageal cancer: An exploratory analysis of the GO2 trial.
Pearce J; Swinson D; Cairns D; Nair S; Baxter M; Petty R; Seymour M; Hall P; Velikova G;
J Geriatr Oncol; 2022 Apr; 13(3):287-293. PubMed ID: 34955446
[TBL] [Abstract][Full Text] [Related]
16. Assessing frailty in older Indian patients before cancer treatment: Comparative analysis of three scales and their implications for overall survival.
Rao AR; Noronha V; Ramaswamy A; Kumar A; Pillai A; Gattani S; Sehgal A; Kumar S; Castelino R; Pearce J; Dhekale R; Jagtap P; Tripathi V; Satamkar S; Krishnamurthy J; Mahajan S; Daptardar A; Sonkusare L; Deodhar J; Ansari N; Vagal M; Mahajan P; Timmanpyati S; Nookala M; Chitre A; Kapoor A; Gota V; Banavali S; Badwe RA; Prabhash K
J Geriatr Oncol; 2024 Apr; 15(3):101736. PubMed ID: 38428186
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.
Agemi Y; Shimokawa T; Sasaki J; Miyazaki K; Misumi Y; Sato A; Aida S; Ishii M; Nakamura Y; Naoki K; Okamoto H
PLoS One; 2019; 14(1):e0210499. PubMed ID: 30653558
[TBL] [Abstract][Full Text] [Related]
18. The preoperative G8 geriatric screening tool independently predicts survival in older patients with endometrial cancer: results of a retrospective single-institution cohort study.
Anic K; Altehoefer C; Krajnak S; Schmidt MW; Schwab R; Linz VC; Schmidt M; Westphalen C; Hartmann EK; Hasenburg A; Battista MJ
J Cancer Res Clin Oncol; 2023 Feb; 149(2):851-863. PubMed ID: 35212815
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group.
Giessen C; Graeven U; Laubender RP; Modest DP; Schulz C; Porschen R; Schmiegel W; Reinacher-Schick A; Hegewisch-Becker S; Stintzing S; Heinemann V
Ann Oncol; 2013 Dec; 24(12):3051-5. PubMed ID: 24130263
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients with Solid Cancers: Protocol for a Danish prospective cohort study (PROGNOSIS-G8).
Ditzel HM; Giger AW; Lund CM; Ditzel HJ; Mohammadnejad A; Pfeiffer P; Ryg J; Jørgensen TL; Ewertz M
J Geriatr Oncol; 2021 Nov; 12(8):1270-1276. PubMed ID: 34176752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
